𝛼SK or Search

ENTITY

China Regenerative Medicine International (8158 HK)

4

Analysis

Health Care • Hong Kong

China Regenerative Medicine International is a high-end new-technology enterprise focused on the research, development, production, and sales of tissue engineering and regenerative medicine products. Its business encompasses tissue engineering, cosmetics, cell storage and therapy, and hospital administration, with key products including ActivSkin and Acornea. The company was incorporated on April 20, 2001, and is headquartered in Hong Kong.

more

Refresh

Exchange Announcement • 17 Sep 2026 17:01

Letter To Non-Registered Shareholder - New Arrangements On Dissemination Of Corporate Communications

Exchange Announcement • 17 Sep 2026 17:00

Letter To Registered Shareholder - New Arrangements On Dissemination Of Corporate Communications And Reply Form

Exchange Announcement • 17 Sep 2026 16:58

Interim Report 2026

Exchange Announcement • 21 Aug 2026 18:39

Interim Results Announcement For The Six Months Ended 30 June 2026

Exchange Announcement • 11 Aug 2026 16:36

Notice Of Board Meeting

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x